Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using carbetocin to prevent postpartum hemorrhage in twin pregnancies; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Postpartum Hemorrhage, Twin Pregnancy | Phase 4 | Status: NOT_YET_RECRUITING